MarketBeat
08 Aug 2026, 04:04 UTC · 2h ago
Ginkgo Bioworks Q2 Earnings Call Highlights
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
MarketBeat
08 Aug 2026, 04:04 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
5 claims · each scored for market impact
Ginkgo Bioworks reported second-quarter 2026 revenue of $20 million, a 48% decline year-over-year. — A near-halving of quarterly revenue suggests a severe contraction in core business demand or a failed transition in business model.
-0.80The company reaffirmed its full-year cash-burn guidance of $125 million to $150 million with $302 million in cash on hand. — While providing visibility, the burn rate relative to cash reserves creates a limited runway for a company with rapidly declining revenues.
-0.40Ginkgo has been selected to build autonomous labs for MIT, Caltech, the University of Maryland, Northwestern University, and Pacific Northwest National Laboratory. — Securing contracts with prestigious academic and government institutions validates the technology and creates a pipeline for future equipment revenue.
+0.30Continue reading
6 related stories
Top 2 movers · tap to explore
The company launched ADME-One, pricing its assay panels at $199, significantly lower than competitors' $1,000 to $5,000 range. — Aggressive underpricing could capture market share from CROs, though it may pressure long-term margins.
+0.20A revised agreement with Google Cloud reduced future minimum commitments by more than $100 million. — Reducing long-term fixed liabilities improves the company's future balance sheet and reduces operational overhead.
+0.20Which stocks this story touches
Revenue declined 48% year-over-year with a reported net loss and negative adjusted EBITDA.
The company faced a reduction in future minimum commitments from Ginkgo Bioworks by over $100 million.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
MarketBeat
1h ago
